Cargando…

European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020

BACKGROUND: The objective of this paper is to provide analytical research that supported the European Commission in setting the global target of additional two healthy life years (HLY) at birth by 2020 in the EU on average, within the European Innovation Partnership on Active and Healthy Ageing (the...

Descripción completa

Detalles Bibliográficos
Autor principal: Lagiewka, Karolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492155/
https://www.ncbi.nlm.nih.gov/pubmed/23088612
http://dx.doi.org/10.1186/0778-7367-70-23
_version_ 1782249069685506048
author Lagiewka, Karolina
author_facet Lagiewka, Karolina
author_sort Lagiewka, Karolina
collection PubMed
description BACKGROUND: The objective of this paper is to provide analytical research that supported the European Commission in setting the global target of additional two healthy life years (HLY) at birth by 2020 in the EU on average, within the European Innovation Partnership on Active and Healthy Ageing (the EIP on AHA). It produces a straightforward analysis of HLY projections that helped the European Commission set a firm, politically sound, target. In order to reach that goal, policy makers need to commit to redefining health priorities and goals and developing and implementing relevant strategies and programmes. METHODS: The study computes a simple simulation of the HLY at birth based on three demographic scenarios: compression of morbidity, expansion of morbidity and an intermediary scenario, the dynamic equilibrium, given the expected 2.1 year gain in male and 1.6 in female life expectancy (LE) by 2020. Data on HLY and projections of life expectancy were obtained from Eurostat and 2008 was taken as a baseline. For consistency and given data gaps, EU27 average values of HLY were calculated. RESULTS: In the EU27 as a whole, the difference between LE and HLY in 2008 was nearly 15 years for men and 20 years for women. The developments of healthy life expectancies across the EU Member States (MSs) are even more diverse that makes it difficult to model any robust EU level trends. Under compression of morbidity, life expectancy and HLY would increase by 2020 on average by 2.1 and 2.0 years for men and by 1.6 and 1.4 years for women respectively. The expected years with disability would remain unchanged while the HLY/LE ratio would improve leading to a 0.5% gain for both genders. Under expansion of morbidity, life expectancy would increase by 2.1 years for men and 1.4 years for women by 2020, while HLY would remain unchanged and the expected years with disability would increase by 2.1 years and 1.6 years in women. This would imply the deterioration of the HLY/LE ratio for both men and women generating a 2.2% and 1.4% loss of health for men and women accordingly. Under dynamic equilibrium, the HLY would increase but to a lesser extent as the rise in life expectancy. The HLY would increase by 1.6 and 1.2 years for men and women respectively. HLY/LE ratio would remain unchanged for both men (+0.1%) and women. The study shows that the first scenario would reduce the HLY gap between the EU MSs by 1.4 years in men and 1.2 years in women, the second would generate no change, while the third one would reduce the gap by 0.9 years in men and increase it by 0.7 years in women. CONCLUSIONS: The results of the study triggered the political decision of setting the global target of 2 additional HLY for the European Innovation Partnership on Active and Healthy Ageing to be achieved by 2020. It is a ‘grand’ goal but can be achieved. Statistics clearly show that EU countries characterise very different levels of health progress, with a gap of 2 decades and diverging trends. With this in mind, the EU HLY target should be complemented by national HLY targets for men and women, set by MSs.
format Online
Article
Text
id pubmed-3492155
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34921552012-11-08 European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020 Lagiewka, Karolina Arch Public Health Research BACKGROUND: The objective of this paper is to provide analytical research that supported the European Commission in setting the global target of additional two healthy life years (HLY) at birth by 2020 in the EU on average, within the European Innovation Partnership on Active and Healthy Ageing (the EIP on AHA). It produces a straightforward analysis of HLY projections that helped the European Commission set a firm, politically sound, target. In order to reach that goal, policy makers need to commit to redefining health priorities and goals and developing and implementing relevant strategies and programmes. METHODS: The study computes a simple simulation of the HLY at birth based on three demographic scenarios: compression of morbidity, expansion of morbidity and an intermediary scenario, the dynamic equilibrium, given the expected 2.1 year gain in male and 1.6 in female life expectancy (LE) by 2020. Data on HLY and projections of life expectancy were obtained from Eurostat and 2008 was taken as a baseline. For consistency and given data gaps, EU27 average values of HLY were calculated. RESULTS: In the EU27 as a whole, the difference between LE and HLY in 2008 was nearly 15 years for men and 20 years for women. The developments of healthy life expectancies across the EU Member States (MSs) are even more diverse that makes it difficult to model any robust EU level trends. Under compression of morbidity, life expectancy and HLY would increase by 2020 on average by 2.1 and 2.0 years for men and by 1.6 and 1.4 years for women respectively. The expected years with disability would remain unchanged while the HLY/LE ratio would improve leading to a 0.5% gain for both genders. Under expansion of morbidity, life expectancy would increase by 2.1 years for men and 1.4 years for women by 2020, while HLY would remain unchanged and the expected years with disability would increase by 2.1 years and 1.6 years in women. This would imply the deterioration of the HLY/LE ratio for both men and women generating a 2.2% and 1.4% loss of health for men and women accordingly. Under dynamic equilibrium, the HLY would increase but to a lesser extent as the rise in life expectancy. The HLY would increase by 1.6 and 1.2 years for men and women respectively. HLY/LE ratio would remain unchanged for both men (+0.1%) and women. The study shows that the first scenario would reduce the HLY gap between the EU MSs by 1.4 years in men and 1.2 years in women, the second would generate no change, while the third one would reduce the gap by 0.9 years in men and increase it by 0.7 years in women. CONCLUSIONS: The results of the study triggered the political decision of setting the global target of 2 additional HLY for the European Innovation Partnership on Active and Healthy Ageing to be achieved by 2020. It is a ‘grand’ goal but can be achieved. Statistics clearly show that EU countries characterise very different levels of health progress, with a gap of 2 decades and diverging trends. With this in mind, the EU HLY target should be complemented by national HLY targets for men and women, set by MSs. BioMed Central 2012-10-22 /pmc/articles/PMC3492155/ /pubmed/23088612 http://dx.doi.org/10.1186/0778-7367-70-23 Text en Copyright ©2012 Lagiewka; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lagiewka, Karolina
European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020
title European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020
title_full European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020
title_fullStr European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020
title_full_unstemmed European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020
title_short European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020
title_sort european innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at eu average by 2020
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492155/
https://www.ncbi.nlm.nih.gov/pubmed/23088612
http://dx.doi.org/10.1186/0778-7367-70-23
work_keys_str_mv AT lagiewkakarolina europeaninnovationpartnershiponactiveandhealthyageingtriggersofsettingtheheadlinetargetof2additionalhealthylifeyearsatbirthateuaverageby2020